Exhibit 5.2
| | | | |
| | | | Eli Lilly and Company Lilly Corporate Center Indianapolis, Indiana 46285 U.S.A. +1.317.276.2000 www.lilly.com |
November 6, 2019
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
Ladies and Gentlemen:
I am the Assistant General Counsel and Assistant Corporate Secretary of Eli Lilly and Company, an Indiana corporation (the “ Company”). I am rendering this opinion in connection with the proposed issuance by the Company, of €600,000,000 aggregate principal amount of the Company’s 0.625% Notes due 2031 and €1,000,000,000 aggregate principal amount of the Company’s 1.700% Notes due 2049 (collectively, the “Debt Securities”) pursuant to a prospectus supplement dated October 29, 2019 (the “Prospectus Supplement”) to the prospectus dated February 19, 2019 contained in the Company’s Registration Statement on FormS-3 (FileNo. 333-229735) (the “Registration Statement”) filed with the U.S. Securities and Exchange Commission (the “Commission”) on February 19, 2019 under the Securities Act of 1933, as amended, and pursuant to an Indenture, dated February 1, 1991, between the Company and Deutsche Bank Trust Company Americas, as trustee (the “Indenture”), and an Underwriting Agreement dated October 29, 2019 (the “Underwriting Agreement”), between the Company and BNP Paribas, Citigroup Global Markets Limited, J.P. Morgan Securities plc, Morgan Stanley & Co. International plc, Academy Securities, Inc., C.L. King & Associates, Inc., Mischler Financial Group, Inc. and Penserra Securities LLC.
I have examined and am familiar with originals, or copies certified or otherwise identified to my satisfaction, of such documents, corporate records, certificates of officers of the Company and of public officials and such other instruments as I have deemed necessary or appropriate as a basis for the opinions expressed below, including the Registration Statement, the Company’s Amended Articles of Incorporation, the Company’s Bylaws, the Indenture, the Debt Securities and the Underwriting Agreement.
For purposes of the opinions expressed below, I have assumed, without independent investigation, that (i) the Indenture and the Underwriting Agreement have been duly authorized, executed and delivered by the parties thereto other than the Company and constitute valid and binding obligations of the parties thereto other than the Company, enforceable against each of them in accordance with their respective terms; and (ii) the certificates representing the Debt Securities will conform as to form to the form of global notes examined by me. I have also